How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances.

Corkery, John Martin; Schifano, Fabrizio; Martinotti, Giovanni

Corkery, John Martin; Schifano, Fabrizio; Martinotti, Giovanni.

Afiliação

Corkery JM; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK.
Schifano F; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK.
Martinotti G; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK.

Br J Clin Pharmacol ; 86(3): 482-498, 2020 03.

Article em En | MEDLINE | ID: mdl-31770457

Assuntos

Drogas Ilícitas; Humanos; Políticas; Psicotrópicos/efeitos adversos

Palavras-chave

clinicians; deaths; information needs; novel psychoactive substances; policy-makers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Drogas Ilícitas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google